Author Correction: Genetically engineered cerebral organoids model brain tumor formation.

ABSTRACT: In the originally published paper, the "before" image for the afatinib condition in Fig. 6c was incorrect. Instead of an image displaying a GBM-3 neoplastic organoid before afatinib treatment, this panel showed an image from the GBM-2 control (DMSO) group before treatment. This error has now been corrected in the HTML and PDF versions of the article; the "before, afatinib" panel in Fig. 6c now shows a representative image from the indicated experiment. The color of all error bars in Fig. 6 has also been changed to black, for consistency. All statistical analysis and all conclusions presented in the article are unaffected by this error. Nevertheless, we apologize for the mistake.

SUBMITTER: Bian S 

PROVIDER: S-EPMC6345371 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature